Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide

NCT00800839 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Hematologic Diseases
Leukemia
Lymphoma
Myeloma

Interventions

DRUG: Busulfan
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center